Rosellini Scientific has appointed Barry Kraynack, MD, to the role of chief medical officer.
Dr. Kraynack is a board certified anesthesiologist with more than 30 years of experience as a preclinical and clinical researcher in translational medicine. He spent 25 of those years as an anesthesiologist, administrator and research physician in private and university practice.
Most recently, Dr. Kraynack served as director of emerging technologies for MicroTransponder, where he developed commercialization plans for neurostimulation technologies. He received his medical degree from the University of Pittsburgh.
Anesthesia Study Identifies Most Common Sources of Bacterial Contamination
8 Recent Anesthesiologist Appointments and Accomplishments
Dr. Kraynack is a board certified anesthesiologist with more than 30 years of experience as a preclinical and clinical researcher in translational medicine. He spent 25 of those years as an anesthesiologist, administrator and research physician in private and university practice.
Most recently, Dr. Kraynack served as director of emerging technologies for MicroTransponder, where he developed commercialization plans for neurostimulation technologies. He received his medical degree from the University of Pittsburgh.
Related Articles on Anesthesia:
Anesthesiologist Dr. Peter Pronovost Co-Develops New Analgesia Pump ChecklistAnesthesia Study Identifies Most Common Sources of Bacterial Contamination
8 Recent Anesthesiologist Appointments and Accomplishments